We chose six brain areas to stain for PERK and eIF2α activation: the pons, medulla, and midbrain (affected in PSP), the hippocampus and frontal cortex (affected in AD), and the cerebellum, which is relatively spared in both diseases. The gene discussed is EIF2AK3; the disease is supranuclear palsy, progressive, 1.